Director, Neuromedicines Discovery Australia; Co-Lead, Neuroscience and Mental Health Therapeutic Program, Monash Institute of Pharmaceutical Sciences
Professor Chris Langmead is the Director of Neuromedicines Discovery Australia and co-leads the Monash Institute of Pharmaceutical Science’s Neuroscience & Mental Health Therapeutic Program.
He is an expert in GPCR drug discovery, particularly in the field of neuropsychiatry, and has led multiple projects into late-stage preclinical development, many of which are now in clinical trials.
He has a degree and PhD in Pharmacology from Queens' College, Cambridge and University College London, respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society and was the recipient of the British Pharmacological Society Novartis Prize in 2017.